(TOP (S (NP (CD Three) (VBG leading) (NN drug) (NNS companies)) (VP (VBD reported) (NP (NP (JJ robust) (JJ third-quarter) (NNS earnings)) (, ,) (VP (VBN bolstered) (PP (IN by) (NP (NP (JJ strong) (NNS sales)) (PP (IN of) (NP (NP (JJR newer) (, ,) (JJ big-selling) (NNS prescriptions) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP provide) (NP (JJ hefty) (NN profit) (NNS margins)))))))))))) (. .)) )
(TOP (S (S (NP (organization (NNP Merck) (CC &) (NNP Co.))) (VP (VBD reported) (NP (NP (DT a) (ADJP (percentage (CD 25) (NN %))) (NN increase)) (PP (IN in) (NP (NNS earnings)))))) (: ;) (S (NP (NP (person (NNP Warner-Lambert) (NNP Co.)) (POS 's)) (NN profit)) (VP (VBD rose) (NP (percentage (CD 22) (NN %))))) (CC and) (S (NP (NP (organization (NNP Eli) (NNP Lilly) (CC &) (NNP Co.)) (POS 's)) (JJ net) (NN income)) (VP (VBD rose) (NP (percentage (CD 24) (NN %))))) (. .)) )
(TOP (S (NP (DT The) (NNS results)) (VP (AUX were) (PP (IN in) (NP (NP (NN line)) (PP (IN with) (NP (NP (NNS analysts) (POS ')) (NNS expectations)))))) (. .)) )
(TOP (NP (organization (NNP Merck) (CC &) (NNP Co) (. .))) )
(TOP (S (NP (NP (organization (NNP Merck))) (, ,) (NP (NP (NNP Rahway)) (, ,) (NP (NNP N.J.))) (, ,)) (VP (VBD continued) (S (VP (TO to) (VP (VB lead) (NP (DT the) (NN industry)) (PP (IN with) (NP (NP (DT a) (JJ strong) (NNS sales) (NN performance)) (PP (IN in) (NP (DT the) (NN human) (CC and) (NN animal) (NNS health-products) (NN segment))))))))) (. .)) )
(TOP (S (NP (DT A) (JJR stronger) (NNP U.S.) (NN dollar)) (VP (VBD reduced) (NP (NN third-quarter) (CC and) (JJ first-nine-month) (NNS sales) (NN growth)) (NP (QP (percentage (CD 2) (NN %)) (CC and) (percentage (CD 3) (NN %)))) (, ,) (ADVP (RB respectively))) (. .)) )
(TOP (S (NP (JJ International) (NNS sales)) (VP (VBD accounted) (PP (IN for) (NP (NP (percentage (CD 47) (NN %))) (PP (IN of) (NP (NP (JJ total) (NN company) (NNS sales)) (PP (IN for) (NP (DT the) (CD nine) (NNS months))))))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (percentage (CD 50) (NN %))) (ADVP (date (NP (DT a) (NN year)) (RBR earlier))))))) (. .)) )
(TOP (S (NP (NP (NNS Sales)) (PP (IN for) (NP (DT the) (NN quarter)))) (VP (VBD rose) (PP (TO to) (NP (QP (money ($ $) (CD 1.63) (CD billion))))) (PP (IN from) (NP (QP (money ($ $) (CD 1.47) (CD billion)))))) (. .)) )
(TOP (S (S (NP (NP (NNP Mevacor)) (, ,) (NP (NP (organization (NNP Merck)) (POS 's)) (JJ new) (JJ cholesterol-lowering) (NN drug)) (, ,)) (VP (AUX had) (NP (NP (JJR higher) (NNS sales)) (SBAR (IN than) (S (NP (DT any) (JJ other) (NN prescription) (NN medicine)) (VP (AUX has) (ADVP (RB ever)) (VP (VBN achieved) (PP (IN in) (NP (DT the) (NNP U.S.))) (PP (IN in) (NP (NP (DT the) (NN year)) (PP (VBG following) (NP (NN introduction)))))))))))) (, ,) (NP (DT the) (NN company)) (VP (VBD said)) (. .)) )
(TOP (S (NP (DT The) (NN drug)) (VP (AUX was) (VP (VBN introduced) (PP (IN in) (NP (location (NNP West) (NNP Germany)))) (NP (date (DT this) (NN year))))) (. .)) )
(TOP (S (NP (JJ Intense) (NN competition)) (, ,) (ADVP (RB however)) (, ,) (VP (VBD led) (PP (TO to) (NP (NP (NN unit) (NNS sales) (NNS declines)) (PP (IN for) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (organization (NNP Merck)) (POS 's)) (VBN established) (NN human) (CC and) (NN animal-health) (NNS products))) (, ,) (PP (VBG including) (NP (NNP Aldomet) (CC and) (NNP Indocin)))))))) (. .)) )
(TOP (S (PP (IN In) (NP (organization (NNP New) (NNP York) (NNP Stock) (NNP Exchange)) (JJ composite) (NN trading))) (NP (date (NN yesterday))) (, ,) (NP (organization (NNP Merck)) (NNS shares)) (VP (VBD closed) (PP (IN at) (NP (money ($ $) (CD 75.25)))) (, ,) (ADVP (RB up) (NP (money (CD 50) (NNS cents))))) (. .)) )
(TOP (NP (organization (NNP Warner-Lambert) (NNP Co) (. .))) )
(TOP (S (NP (NP (NNP Warner-Lambert)) (, ,) (NP (NP (person (NNP Morris) (NNP Plains))) (, ,) (NP (NNP N.J.))) (, ,)) (VP (VBD reported) (NP (NP (NNS sales)) (SBAR (WHNP (WDT that)) (S (VP (AUX were) (NP (NP (NP (DT a) (NN record)) (PP (IN for) (NP (DT any) (NN quarter)))) (CC and) (NP (NP (DT the) (JJ eighth) (NN quarter)) (PP (IN in) (NP (DT a) (NN row))) (PP (IN of) (NP (QP (percentage (CD 20) (NN %)) (CC or) (JJR more)) (JJ per-share) (NNS earnings) (NN growth)))))))))) (. .)) )
(TOP (S (S (VP (VBN Spurred) (PP (IN by) (NP (NP (NN growth)) (PP (IN in) (NP (NP (JJ world-wide) (NNS sales)) (PP (IN of) (NP (NP (DT the) (NN company) (POS 's)) (NN prescription) (NNS drugs))))))))) (, ,) (NP (NNP Warner-Lambert)) (VP (VBD said) (SBAR (S (NP (date (CD 1989))) (VP (MD will) (VP (AUX be) (NP (NP (DT the) (JJS best) (NN year)) (PP (IN in) (NP (PRP$ its) (NN history)))) (, ,) (SBAR (IN with) (S (NP (JJ per-share) (NNS earnings)) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (NP (percentage (QP (JJR more) (IN than) (CD 20)) (NN %))) (PP (TO to) (NP (QP (RB about) ($ $) (CD 6.10))))))))))))))) (. .)) )
(TOP (S (NP (NP (NNS Sales)) (PP (IN for) (NP (DT the) (NN quarter)))) (VP (VBD rose) (PP (TO to) (NP (QP (money ($ $) (CD 1.11) (CD billion))))) (PP (IN from) (NP (QP (money ($ $) (CD 1.03) (CD billion)))))) (. .)) )
(TOP (S (S (NP (NN Prescription-drug) (JJ world-wide) (NNS sales)) (VP (VBD rose) (NP (percentage (CD 9) (NN %))) (PP (IN in) (NP (DT the) (NN quarter))) (PP (TO to) (NP (QP (money ($ $) (CD 340) (CD million))))))) (: ;) (S (NP (NNP U.S.) (NNS sales)) (VP (VBD rose) (NP (percentage (CD 15) (NN %))))) (. .)) )
(TOP (S (NP (NP (DT The) (NN segment) (POS 's)) (NN growth)) (VP (AUX was) (VP (VBN led) (PP (IN by) (NP (NP (NNS sales)) (PP (IN of) (NP (NP (DT the) (JJ cardiovascular) (NNS drugs)) (NP (NP (NP (NNP Lopid)) (, ,) (NP (DT a) (NN lipid) (NN regulator)) (, ,)) (CC and) (NP (NP (NNP Dilzem)) (, ,) (NP (DT a) (NN calcium) (NN channel) (NN blocker)))))))))) (. .)) )
(TOP (S (S (NP (NP (JJ World-wide) (NNS sales)) (PP (IN of) (NP (NP (NP (NNP Warner-Lambert) (POS 's)) (JJ non-prescription) (NN health-care) (NNS products)) (, ,) (PP (JJ such) (IN as) (NP (NP (NNP Halls) (NN cough) (NNS tablets)) (, ,) (NP (NNP Rolaids) (NN antacid)) (, ,) (CC and) (NP (NNP Lubriderm) (NN skin) (NN lotion)))) (, ,)))) (VP (VBD increased) (NP (percentage (CD 3) (NN %))) (PP (TO to) (NP (QP (money ($ $) (CD 362) (CD million))))) (PP (IN in) (NP (DT the) (date (JJ third) (NN quarter)))))) (: ;) (S (NP (NNP U.S.) (NNS sales)) (VP (VBD rose) (NP (percentage (CD 5) (NN %))))) (. .)) )
(TOP (S (NP (JJ Confectionery) (NNS products) (NNS sales)) (ADVP (RB also)) (VP (AUX had) (NP (JJ strong) (NN growth)) (PP (IN in) (NP (DT the) (NN quarter)))) (. .)) )
(TOP (S (NP (NP (JJ World-wide) (NNS sales)) (PP (IN of) (NP (NP (NNP Trident) (NN gum)) (, ,) (NP (NNP Certs) (NN breath) (NNS mints)) (, ,) (CC and) (NP (NNP Clorets) (NN gum) (CC and) (NN breath) (NNS mints)) (, ,)))) (VP (VBD increased) (NP (percentage (CD 12) (NN %))) (PP (TO to) (NP (QP (money ($ $) (CD 277) (CD million)))))) (. .)) )
(TOP (S (NP (NNP Warner-Lambert) (NNS shares)) (VP (VBD closed) (PP (IN at) (NP (NP (money ($ $) (CD 109.50))) (NP (DT a) (NN share)))) (, ,) (ADVP (RB up) (NP (money ($ $) (CD 1.50)))) (, ,) (PP (IN in) (NP (NNP Big) (NNP Board) (JJ composite) (NN trading))) (NP (date (NN yesterday)))) (. .)) )
(TOP (NP (organization (NNP Eli) (NNP Lilly) (CC &) (NNP Co) (. .))) )
(TOP (S (NP (NNP Lilly)) (VP (VBD attributed) (NP (NN record) (JJ third-quarter) (CC and) (JJ nine-month) (NNS results)) (PP (TO to) (NP (NP (JJ world-wide) (NNS gains)) (PP (IN for) (NP (NP (NNS pharmaceuticals)) (, ,) (NP (JJ medical) (NNS instruments)) (CC and) (NP (NN plant-science) (NNS products)))) (PP (IN despite) (NP (NP (JJ poor) (NN exchange) (NNS rates)) (PP (IN for) (NP (DT the) (NN dollar))) (SBAR (WHNP (WDT that)) (S (VP (VBD slowed) (NP (NP (NNS sales)) (ADVP (RB abroad))))))))))) (. .)) )
(TOP (S (NP (NNS Earnings)) (VP (VBD continued) (S (VP (TO to) (VP (VB pace) (NP (NNS sales)) (PP (IN because) (IN of) (NP (NP (DT a) (JJR lower) (NN tax) (NN rate)) (, ,) (NP (NP (NN profit)) (PP (IN from) (NP (NP (DT the) (NN renegotiation)) (PP (IN of) (NP (NP (DT the) (NN debt) (NN instrument)) (VP (VBN received) (PP (IN from) (NP (NNP Faberge) (NNP Inc.))) (PP (IN in) (NP (NP (NN connection)) (PP (IN with) (NP (NP (NP (person (NNP Lilly)) (POS 's)) (NN sale)) (PP (IN of) (NP (NP (person (NNP Elizabeth) (NNP Arden) (NNP Inc.))) (PP (IN in) (NP (date (CD 1987)))))))))))))))) (, ,) (CC and) (NP (NP (JJ net) (NNS proceeds)) (PP (IN from) (NP (NP (DT the) (NN settlement)) (PP (IN of) (NP (NN patent) (NN litigation))) (PP (IN at) (NP (NP (NNP Lilly) (POS 's)) (organization (person (NNP Hybritech) (NNP Inc.))) (NN unit)))))))))))) (. .)) )
(TOP (S (NP (NP (JJ Third-quarter) (NNS sales)) (PP (IN of) (NP (DT the) (NAC (location (NNP Indianapolis)) (, ,) (person (NNP Ind.)) (, ,)) (NN company)))) (VP (VBD rose) (NP (percentage (CD 11) (NN %))) (PP (TO to) (NP (QP (money ($ $) (CD 1.045) (CD billion))))) (PP (IN from) (NP (QP (money ($ $) (CD 940.6) (CD million)))))) (. .)) )
(TOP (S (NP (JJ Nine-month) (NNS sales)) (VP (VBD grew) (NP (percentage (CD 12) (NN %))) (PP (TO to) (NP (QP (money ($ $) (CD 3.39) (CD billion))))) (PP (IN from) (NP (QP (money ($ $) (CD 3.03) (CD billion)))) (ADVP (date (NP (DT a) (NN year)) (RBR earlier))))) (. .)) )
(TOP (S (NP (NP (NNS Sales)) (PP (IN of) (NP (NP (NNP Prozac)) (, ,) (NP (DT an) (NN anti-depressant)) (, ,)))) (VP (VBD led) (NP (NNS drug-sales) (NNS increases))) (. .)) )
(TOP (S (S (NP (NP (JJR Higher) (NNS sales)) (PP (IN of) (NP (NP (NNS pesticides)) (CC and) (NP (JJ other) (NN plant-science) (NNS products))))) (VP (ADVP (RBR more) (IN than)) (VBP offset) (NP (NP (DT a) (JJ slight) (NN decline)) (PP (IN in) (NP (NP (DT the) (NNS sales)) (PP (IN of) (NP (NN animal-health) (NNS products)))))) (S (VP (TO to) (VP (VB fuel) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (JJ world-wide) (JJ agricultural) (NN product) (NNS sales))))))))) (, ,) (NP (person (NNP Lilly))) (VP (VBD said)) (. .)) )
(TOP (S (NP (NP (organization (NNP Advanced) (NNP Cardiovascular) (NNPS Systems) (NNP Inc.))) (CC and) (NP (NNP Cardiac) (NNPS Pacemakers) (NNP Inc.) (NNS units))) (VP (VBD led) (NP (NP (NN growth)) (PP (IN in) (NP (DT the) (JJ medical-instrument) (NNS systems) (NN division))))) (. .)) )
(TOP (S (NP (NNP Lilly) (NNS shares)) (VP (VBD closed) (NP (date (NN yesterday))) (PP (IN in) (NP (NP (JJ composite) (NN trading)) (PP (IN on) (NP (DT the) (NNP Big) (NNP Board))))) (PP (IN at) (NP (money ($ $) (CD 62.25)))) (, ,) (ADVP (RB down) (NP (money (CD 12.5) (NNS cents))))) (. .)) )
